The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
Open Access
- 9 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 17 (1), 1-4
- https://doi.org/10.1186/s13223-021-00607-5
Abstract
C1 inhibitor (C1-INH) and complement 4 (C4) have historically been referred to as positive acute phase reactants, however this has never been evaluated in hereditary angioedema (HAE) patients. Low function of C1-INH and low levels of C4 are important in the diagnosis of HAE type 1 and 2. If C1-INH and/or C4 are significant acute phase reactants, their levels may be falsely “normal” in patients with HAE when measured during times of infection or inflammation resulting in missed or delayed diagnosis. We present a case series of four HAE patients who had C4, C1-INH, c-reactive protein (CRP) and ferritin measured at baseline and again during a self-reported upper respiratory tract infection (URTI) or flu-like illness. We did not identify any HAE patients who had a significant change in their C1-INH functional level in the context of a mild infection. However, the C4 level did increase into the normal range on three occasions (2 patients, with 1 patient having elevation during two separate illnesses). C1 inhibitor may not be a clinically significant acute phase protein and appears to still be a reliable diagnostic marker of hereditary angioedema, even in times of modest acute inflammation, unlike complement C4 which can be elevated in this setting.Keywords
This publication has 7 references indexed in Scilit:
- Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapyJournal of Allergy and Clinical Immunology, 2010
- The pathophysiology of hereditary angioedemaClinical Immunology, 2005
- Hereditary AngioedemaArchives of Internal Medicine, 2001
- Regulation of C1 Inhibitor SynthesisImmunobiology, 1998
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 β and interleukin-6 in the human hepatoma cell line PLC/PRF/5Biochemical Journal, 1991
- Serum inhibitor of C'1-esterase in health and disease.1966